The global subcutaneous implantable defibrillator market is set to witness significant growth in the coming decade, driven by an escalating burden of cardiovascular diseases worldwide. Valued at US$ 8.34 billion in 2022, the market is predicted to soar to US$ 12.44 billion by 2032, reflecting a steady CAGR of 4.3%.
According to the World Health Organization (WHO), poor and middle-income countries bear the brunt of cardiovascular disease deaths, accounting for more than three-quarters of the total. Heart attacks and strokes, constituting over 80% of Defibrillator Disease fatalities, afflict individuals, including adults under 70, with devastating consequences.
Get Access to Sample Now: https://www.futuremarketinsights.com/reports/sample/rep-gb-2436
Recognizing the imperative for innovative solutions to combat cardiovascular diseases, the S-ID emerges as a beacon of hope. Offering distinct advantages over traditional Implantable Defibrillators (ID), S-ID systems minimize risks associated with transvenous leads, such as bloodstream infections, while facilitating easier lead removal and replacement. Unlike ID systems where leads are positioned within veins, S-ID implants leads beneath the skin, enhancing patient safety and convenience.
“The burgeoning prevalence of cardiovascular disorders underscores the critical need for advanced treatment modalities,” remarked at FMI. “As heart attacks and strokes continue to claim lives, there’s an urgent demand for efficacious interventions like subcutaneous implantable defibrillator systems.”
The exponential growth of the S-ID market is propelled by the increasing incidence of cardiovascular illnesses and life-threatening arrhythmias. As heart-related ailments remain a leading cause of mortality globally, accounting for an estimated 43% of deaths, the necessity for enhanced treatment avenues becomes paramount.
Subcutaneous Implantable Defibrillator Market: Key Drivers and Restraints
Drivers:
- Advantages over Conventional Defibrillators: Subcutaneous implantable defibrillators (S-ICDs) offer several benefits compared to traditional implantable cardioverter-defibrillators (ICDs):
- Electrode Placement: S-ICDs place the electrode under the skin near the heart, reducing the risk of complications associated with placing electrodes directly on the heart muscle in conventional ICDs.
- Longer Shelf Life: S-ICDs potentially have a longer lifespan than traditional ICDs, requiring fewer replacements.
- Ease of Insertion and Removal: S-ICDs are generally easier to implant and remove than traditional ICDs due to their less invasive placement.
- Rising Cardiovascular Disease: The increasing prevalence of cardiovascular diseases globally is a major driver for the S-ICD market. As these conditions put individuals at risk of sudden cardiac arrest, the demand for preventative measures like S-ICDs rises.
- Growing Geriatric Population: The aging population worldwide is more susceptible to cardiovascular issues. This creates a larger potential patient pool for S-ICDs.
- Lifestyle Factors: Lifestyle changes like increased smoking and unhealthy eating habits contribute to cardiovascular disease. As public health awareness grows, the demand for preventative measures like S-ICDs may also increase.
- Technological Advancements: The medical device industry’s continuous advancements in S-ICD technology improve their efficacy and safety, making them a more attractive option.
Restraints:
- Patient Limitations: S-ICDs are not suitable for everyone. Patients with specific conditions like symptomatic ventricular bradycardia or needing heart failure resynchronization cannot use S-ICDs due to potential complications.
- Limited Clinical Data: While S-ICDs show promise, their long-term effectiveness in the general population still requires more clinical data and research.
Overall, the S-ICD market is expected to grow due to its advantages over traditional defibrillators and the rising burden of cardiovascular diseases. However, patient limitations and the need for further clinical validation remain challenges.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-2436
Subcutaneous Implantable Defibrillator Market: Key Players
Some of the key players in global Implantable Defibrillator market include Boston Scientific Corporation, LivaNova PLC Company, Imricor Medical Systems, Inc., MicroPort Scientific Corporation, Mayo Clinic US, Medtronic plc, MRI Interventions, Inc., and St. Jude Medical, Inc.
Subcutaneous Implantable Defibrillator Market: Segmentation
The global Implantable Defibrillator market is classified on the basis of product type, procedure type, end user, and geography.
Based on indications, the global Subcutaneous Implantable Defibrillator market is segmented into the following:
- Ventricular Tachycardia
- Hypertrophic Cardiomyopathy
- Ventricular Dysplasia
- Others
Based on end user, the global Implantable Defibrillator market is segmented into the following:
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Home care settings
Regional analysis includes:
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Japan
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
Direct Purchase of this Report: https://www.futuremarketinsights.com/checkout/2436
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
